GRP
CALT

Global Retirement Partners’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Global Retirement Partners’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-500
Closed -$19.5K – 3668
2024
Q2 		$19.5K Buy
+500
New +$13.7K ﹤0.01% 1993

Other funds holding CALT

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return

Global Retirement Partners's CALT Position: Q3 2024 in Review

Global Retirement Partners sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 500 shares — an estimated $19.5K sold.

Global Retirement Partners first reported a position in CALT in Q2 2024 and held it in 1 quarter. The position peaked at $19.5K in Q2 2024. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.

  • Global Retirement Partners reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Global Retirement Partners sold 500 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $19.5K.
  • Global Retirement Partners first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2024 and held it in 1 quarter.
  • Global Retirement Partners's Calliditas Therapeutics AB American Depositary Shares position peaked at $19.5K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.

Based on Global Retirement Partners's 13F filing for Q3 2024, filed 16 Oct 2024.